Robert H Eckel Selected Research

4-hydroxyphenylglycine (oxfenicine)

1/2022

Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert H Eckel Research Topics

Disease

33	Obesity 09/2020 - 04/2002
29	Insulin Resistance 01/2021 - 04/2002
28	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 11/2004
20	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2006
20	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2021 - 04/2002
18	Weight Loss (Weight Reduction) 01/2019 - 11/2002
12	Body Weight (Weight, Body) 10/2017 - 04/2005
10	Hypertriglyceridemia 05/2021 - 02/2003
9	Dyslipidemias (Dyslipidemia) 01/2019 - 05/2005
8	Atherosclerosis 01/2022 - 11/2002
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 02/2003
7	Hyperglycemia 01/2017 - 06/2006
7	Coronary Disease (Coronary Heart Disease) 12/2016 - 12/2002
6	Hypertension (High Blood Pressure) 01/2022 - 02/2003
5	Glucose Intolerance 10/2022 - 06/2003
5	Prediabetic State (Prediabetes) 01/2022 - 08/2008
5	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 02/2010
5	Inflammation (Inflammations) 05/2016 - 06/2004
5	Weight Gain 08/2014 - 08/2004
4	Morbid Obesity 01/2020 - 09/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 02/2011
3	Abdominal Obesity 11/2021 - 10/2009
3	Hyperlipidemias (Hyperlipidemia) 11/2021 - 01/2018
3	Heart Diseases (Heart Disease) 01/2018 - 02/2009
3	Neoplasms (Cancer) 08/2015 - 11/2012
2	Cognitive Dysfunction 01/2022 - 01/2015
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2018
2	Sleep Deprivation 03/2020 - 04/2013
2	Vascular Diseases (Vascular Disease) 10/2019 - 08/2011
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2019 - 01/2018
2	Hypercholesterolemia 01/2019 - 03/2010
2	Pancreatitis 01/2019 - 01/2018
2	Diabetes Mellitus 01/2019 - 05/2016
2	Fatty Liver 01/2018 - 05/2007
2	Infections 01/2018 - 02/2011
2	Hyperinsulinism (Hyperinsulinemia) 01/2017 - 06/2006
2	Muscular Diseases (Myopathy) 01/2015 - 05/2010
2	Overweight 05/2012 - 04/2006
2	Acute Coronary Syndrome 11/2002 - 09/2002
1	Atherosclerotic Plaque (Atheroma) 06/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Pulmonary Arterial Hypertension 01/2022

Drug/Important Bio-Agent (IBA)

38	LipidsIBA 01/2022 - 01/2002
25	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2002
23	Triglycerides (Triacylglycerol)IBA 05/2021 - 09/2002
20	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2019 - 01/2002
19	Insulin (Novolin)FDA Link 01/2022 - 09/2002
15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 09/2002
14	Lipoproteins (Lipoprotein)IBA 10/2018 - 02/2003
12	HDL CholesterolIBA 11/2021 - 10/2009
8	oxidized low density lipoproteinIBA 10/2022 - 12/2007
7	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 09/2002
7	CarbohydratesIBA 09/2017 - 05/2003
6	CholesterolIBA 01/2022 - 05/2005
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 09/2002
6	LeptinIBA 04/2013 - 04/2002
6	AdiponectinIBA 09/2007 - 06/2003
5	EnzymesIBA 01/2022 - 06/2003
5	Pharmaceutical PreparationsIBA 11/2021 - 04/2005
5	LDL CholesterolIBA 12/2014 - 02/2003
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2021 - 01/2016
4	CalciumIBA 01/2021 - 05/2004
4	ApolipoproteinsIBA 01/2021 - 08/2014
4	CytokinesIBA 01/2021 - 11/2002
4	Lipoprotein(a)IBA 01/2019 - 02/2011
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2002
4	AndrogensIBA 01/2018 - 02/2010
3	eicosapentaenoic acid ethyl esterIBA 06/2022 - 01/2020
3	Apolipoproteins B (ApoB)IBA 11/2021 - 10/2015
3	MelatoninIBA 03/2020 - 04/2013
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2011
3	Anti-Obesity Agents (Antiobesity Drugs)IBA 12/2014 - 06/2011
3	VLDL LipoproteinsIBA 11/2014 - 08/2004
3	Hormones (Hormone)IBA 04/2013 - 01/2009
3	C-Reactive ProteinIBA 12/2006 - 09/2002
3	Lipase (Acid Lipase)FDA Link 11/2003 - 04/2002
2	SodiumIBA 01/2022 - 12/2014
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 11/2020
2	HDL LipoproteinsIBA 01/2021 - 05/2016
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2020 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2018 - 02/2011
2	ThiazolidinedionesIBA 01/2018 - 12/2014
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 12/2014
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 12/2014
2	CeramidesIBA 01/2018 - 10/2017
2	Simvastatin (Zocor)FDA LinkGeneric 03/2017 - 12/2006
2	lipoprotein cholesterolIBA 01/2017 - 07/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2015 - 05/2010
2	FatsIBA 04/2013 - 02/2009
2	Fenofibrate (CiL)FDA LinkGeneric 08/2011 - 02/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2006 - 06/2004
1	EstersIBA 06/2022
1	AcidsIBA 06/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022

Therapy/Procedure

24	Therapeutics 01/2022 - 06/2004
10	Bariatric Surgery 01/2020 - 06/2011
4	Glycemic Control 10/2019 - 10/2003
4	Injections 01/2017 - 03/2011
1	Precision Medicine 10/2022